Skip to main content

Medtronic's $43B Covidien deal: More to come?

Medtronic's $43 billion Covidien deal, which boosts its negotiating power for the Affordable Care Act, may be a sign of future medical-device mergers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.